Johnson Controls Is a Low-Risk Buy for Patient Investors

NEW YORK (Real Money) -- Johnson Controls (JCI) shares were attracting very heavy trade Thursday following an upgrade from UBS analysts, who lifted the stock to buy from neutral, sparking a powerful upside gap. By the final hour of trading, JCI was stabilizing with a 3% gain and putting it second on the S&P 500's list of gainers.

Last month, following its second-quarter earnings report, JCI ramped up more than 3% on its heaviest trade in over a year. The surge pushed shares to fresh 2015 highs before piercing the 2014 peak of $52.50. Despite this breakout-type action into new all-time high territory, the momentum died quickly. Over the next 11 sessions JCI fell 10 times. This pullback dropped the stock back down to the middle of its 10-week range. Up until last Friday, JCI remained in a tight, low-volume range with little direction. As last week ended, the stock began to perk up with the help of a nice spike in bullish interest.

Now JCI is building on last week's improvement and is set up well for more upside. Supply near the April spike high is a battleground Thursday but I doubt this will hold back the stock for long. Despite trading back up near its all-time highs, shares are far from overbought. It would take quite a run for shares to return to the overbought levels reached in November and March.

I have a small long position in JCI and will look to add on weakness. The stock has a very solid layer of nearby support around the $51.75 area. This support zone includes the March high ($52) as well as today's upgrade-driven breakout gap ($51.60). If the stock needs a rest before clearing the April peak, I expect this area to hold. The stock is a low-risk buy for patient bulls.

Editor's Note: This article was originally published at 3:40 p.m. EDT on Real Money on May 28.

At the time of publication, Morrow had a position in JCI.

If you liked this article you might like

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Stay Defensive With Johnson Controls

Stay Defensive With Johnson Controls

13 Stocks Investors Should Short if Inflation Remains Low

13 Stocks Investors Should Short if Inflation Remains Low

It's Been a Fine Earnings Season, but Here Come the Retailers: Market Recon

It's Been a Fine Earnings Season, but Here Come the Retailers: Market Recon

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges